Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest-Reference-Cited by-同舟云学术

Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest

Published:2022-04 Issue:6 Volume:17 Page:449-463
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Saba Abdullah Al¹^ORCID,Adiba Maisha¹^ORCID,Chakraborty Sajib²^ORCID,Nabi AHM Nurun¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Laboratory of Population Genetics, University of Dhaka, Dhaka, 1000, Bangladesh

2. Department of Biochemistry and Molecular Biology, Systems Cell-Signalling Laboratory, University of Dhaka, Dhaka, 1000, Bangladesh

Abstract

Aim: To predict siRNAs as a therapeutic intervention for highly infectious new variants of SARS-CoV-2. Methods: Conserved coding sequence regions of 11 SARS-CoV-2 proteins were used to construct siRNAs through sampling of metadata comprising 214,256 sequences. Results: Predicted siRNAs S1: 5′-UCAUUGAGAAAUGUUUACGCA-3′ and S2: 5′-AAAGACAUCAGCAUACUCCUG-3′ against RdRp of SARS-CoV-2 satisfied all the stringent filtering processes and showed good binding characteristics. The designed siRNAs are expected to inhibit viral replication and transcription of various coronavirus strains encompassing variants of concern and interest. Conclusion: The predicted siRNAs are expected to be potent against SARS-CoV-2, and following in vitro and in vivo validations may be considered as potential therapeutic measures.

Funder

Information and Communication Technology Division Under the Ministry of Posts, Telecommunications and Information Technology, Government of the People's Republic of Bangladesh

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fmb-2021-0130

Reference63 articles.

1. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

2. Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach

3. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

4. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

5. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV-1;Biochemical and Biophysical Research Communications;2024-05

2. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges;Future Virology;2024-03-03

3. Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs: A Comprehensive Bioinformatics Study with Generative Adversarial Network-Based Peptide Design and In Vitro Assays;Molecular Pharmaceutics;2023-11-09

4. RNA Interference Approach Is a Good Strategy against SARS-CoV-2;Viruses;2022-12-29

5. Most frequently harboured missense variants of hACE2 across different populations exhibit varying patterns of binding interaction with spike glycoproteins of emerging SARS-CoV-2 of different lineages;Computers in Biology and Medicine;2022-09